Of late, there has been an evident shift in interest to non-invasive immunization methods, which include oral, intranasal and transdermal modes of administration. Currently, many biopharmaceutical companies and clinical research institutes are engaged in the development of novel vaccine delivery systems, taking into consideration the specific requirements of large scale immunization initiatives. As a result, significant efforts have been put into the development of drug delivery technologies / devices, such as microneedle patches, electroporation-based needle free injection systems, jet injectors, inhalation-based delivery systems, biodegradable implants and certain novel types of oral delivery systems. It is worth highlighting that most of the aforementioned systems are specifically being designed to facilitate pain-free administration of vaccines and allow self-administration.
To order this 500+ page report, which features 90+ figures and 160+ tables, please visit this
The USD 1.5 billion (by 2030) financial opportunity within the novel vaccine delivery devices market has been analyzed across the following segments:
- Type of device
- Electroporation-based needle free injection system
- Oral delivery systems
- Nasal delivery systems
- Jet injectors
- Microneedle patches
- Microinjectors
- Type of vaccine
- Key geographical regions
- North America
- Europe
- Asia Pacific
- Rest of the world
The report features the following companies, which we identified to be key players in this domain:
Table of Contents
- PREFACE
- EXECUTIVE SUMMARY
- INTRODUCTION
- MARKET LANDSCAPE
- DEVICE COMPETITIVENESS ANALYSIS
- TECHNOLOGY EFFECTIVENESS ANALYSIS
- NOVEL VACCINE DELIVERY DEVICES: LIKELY VACCINE CANDIDATES
- COMPANY PROFILES
- PARTNERSHIPS AND COLLABORATIONS
- SWOT ANALYSIS
- MARKET SIZING AND OPPORTUNITY ANALYSIS
- EXECUTIVE INSIGHTS
- CONCLUDING REMARKS
- APPENDIX I: TABULATED DATA
To purchase a copy, please visit or email
Contact Details
Gaurav Chaudhary
+1 (415) 800 3415